Literature DB >> 20609959

Linking diabetes and cancer: a consensus on complexity.

Andrew Renehan1, Ulf Smith, M Sue Kirkman.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20609959     DOI： 10.1016/S0140-6736(10)60706-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  36 in total

Review 1.  Overweight, obesity, diabetes, and risk of breast cancer: interlocking pieces of the puzzle.

Authors:  Carlo La Vecchia; Sharon H Giordano; Gabriel N Hortobagyi; Bruce Chabner
Journal:  Oncologist       Date:  2011-05-31

2.  Cancer and diabetes: are we ready for prime time?

Authors:  U Smith; E A M Gale
Journal:  Diabetologia       Date:  2010-06-13       Impact factor: 10.122

3.  Metformin: are potential benefits on cancer risk extended to cancer survival?

Authors:  Carlo La Vecchia; Cristina Bosetti
Journal:  Oncologist       Date:  2013-11-20

Review 4.  Insights into the relationships between diabetes, prediabetes, and cancer.

Authors:  Lorenzo Scappaticcio; Maria Ida Maiorino; Giuseppe Bellastella; Dario Giugliano; Katherine Esposito
Journal:  Endocrine       Date:  2016-12-31       Impact factor: 3.633

5.  Prospective study of self-reported diabetes and risk of upper gastrointestinal cancers.

Authors:  Shih-Wen Lin; Neal D Freedman; Albert R Hollenbeck; Arthur Schatzkin; Christian C Abnet
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-03-17       Impact factor: 4.254

6.  Linking prediabetes and cancer: a complex issue.

Authors:  Dario Giugliano; Maria Ida Maiorino; Katherine Esposito
Journal:  Diabetologia       Date:  2014-10-25       Impact factor: 10.122

7.  Insulin analogues and cancer risk: the emergence of second-generation studies.

Authors:  A G Renehan
Journal:  Diabetologia       Date:  2011-10-28       Impact factor: 10.122

8.  Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer.

Authors:  X He; F J Esteva; J Ensor; G N Hortobagyi; M-H Lee; S-C J Yeung
Journal:  Ann Oncol       Date:  2011-11-22       Impact factor: 32.976

Review 9.  Cancer risk for patients using thiazolidinediones for type 2 diabetes: a meta-analysis.

Authors:  Cristina Bosetti; Valentina Rosato; Danilo Buniato; Antonella Zambon; Carlo La Vecchia; Giovanni Corrao
Journal:  Oncologist       Date:  2013-01-23

10.  Hyperglycemia is a significant prognostic factor of hepatocellular carcinoma after curative therapy.

Authors:  Takanori Hosokawa; Masayuki Kurosaki; Kaoru Tsuchiya; Shuya Matsuda; Masaru Muraoka; Yuichiro Suzuki; Nobuharu Tamaki; Yutaka Yasui; Toru Nakata; Takashi Nishimura; Shoko Suzuki; Ken Ueda; Hiroyuki Nakanishi; Jun Itakura; Yuka Takahashi; Namiki Izumi
Journal:  World J Gastroenterol       Date:  2013-01-14       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.